Terkko Navigator / -/ Feeds / " ( ( Interleukiini-6 )|( IL-6 )|( Interleukiini 6 )|( Interleukin-6 )|( Interleukin 6 )|( "

Interleukin-6 Receptor Blockade can Increase the Risk of Nonalcoholic Fatty Liver Disease: Indications From Mendelian Randomization

Interleukin-10-Modified Adipose-Derived Mesenchymal Stem Cells Prevent Hypertrophic Scar Formation via Regulating the Biological Characteristics of Fibroblasts and Inflammation

IFN-beta protects from vascular leakage via up-regulation of CD73.

IFN-beta regulates CD73 and adenosine expression at the blood-brain barrier.

IFN-beta protects from vascular leakage via up-regulation of CD73.

IFN-beta regulates CD73 and adenosine expression at the blood-brain barrier.

TLR2 Utilization of Borrelia Does Not Induce p38- and IFN-{beta} Autocrine Loop-Dependent Expression of CD38, Resulting in Poor Migration and Weak IL-12 Secretion of Dendritic Cells.

TLR2 utilization of Borrelia does not induce p38- and IFN-beta autocrine loop-dependent expression of CD38, resulting in poor migration and weak IL-12 secretion of dendritic cells

Increased disability and MRI lesions after discontinuation of IFN-beta-1a in secondary progressive MS.

Once-weekly 22mug subcutaneous IFN-beta-1a in secondary progressive MS: a 3-year follow-up study on brain MRI measurements and serum MMP-9 levels.

Once-weekly 22mug subcutaneous IFN-beta-1a in secondary progressive MS: a 3-year follow-up study on brain MRI measurements and serum MMP-9 levels.

Mechanism of Action of IFN-beta in the Treatment of Multiple Sclerosis: A Special Reference to CD73 and Adenosine.

MxA protein assay for optimal monitoring of IFN-beta bioactivity in the treatment of MS patients.

Once-weekly 22microg subcutaneous IFN-beta-1a in secondary progressive MS: a 3-year follow-up study on brain MRI measurements and serum MMP-9 levels.

Glucocorticoids inhibit type I IFN beta signaling and the upregulation of CD73 in human lung.

Glucocorticoids inhibit type I IFN beta signaling and the upregulation of CD73 in human lung.

Glucocorticoids inhibit type I IFN beta signaling and the upregulation of CD73 in human lung.

Glucocorticoids inhibit type I IFN beta signaling and the upregulation of CD73 in human lung

IFN-beta 1b and Remdesivir for COVID19

IL-21 enhances SOCS gene expression and inhibits LPS-induced cytokine production in human monocyte-derived dendritic cells.

IFN Regulatory Factor Family Members Differentially Regulate the Expression of Type III IFN (IFN-{lambda}) Genes.

IFN Regulatory Factor 3 in Health and Disease [BRIEF REVIEWS]

Cardiometabolic effects of genetic upregulation of the interleukin 1 receptor antagonist: a Mendelian randomisation analysis.

Cardiometabolic effects of genetic upregulation of the interleukin 1 receptor antagonist: a Mendelian randomisation analysis.

Cardiometabolic effects of genetic upregulation of the interleukin 1 receptor antagonist: a Mendelian randomisation analysis.

Interleukin 7 receptor drives Early T lineage Progenitor expansion

Interleukin 2-Based Fusion Proteins for the Treatment of Cancer

Interleukin 2-Based Fusion Proteins for the Treatment of Cancer

IL-17RA-signaling in Lgr5+ intestinal stem cells induces expression of transcription factor ATOH1 to promote secretory cell lineage commitment

Interleukin 10 Attenuates Angiotensin II-Induced Aortic Remodelling by Inhibiting Oxidative Stress-Induced Activation of the Vascular p38 and NF-κB Pathways

IL-10 polymorphism and cell-mediated immune response to Chlamydia trachomatis.

IL-38 Alleviates Inflammation in Sepsis in Mice by Inhibiting Macrophage Apoptosis and Activation of the NLRP3 Inflammasome

Differentiation of Human Pluripotent Stem Cells Into Definitive Endoderm Cells in Various Flexible Three-Dimensional Cell Culture Systems : Possibilities and Limitations

IL-6 Promotes Hepatocellular Carcinoma Invasion by Releasing Exosomal miR-133a-3p

IL-13 deficiency exacerbates lung damage and impairs epithelial-derived type 2 molecules during nematode infection

IL-33 promotes innate lymphoid cell-dependent IFN-γ production required for innate immunity to Toxoplasma gondii

IL-36 in chronic inflammation and fibrosis — bridging the gap?

IL-21/IL-21R Regulates the Neutrophil-Mediated Pathologic Immune Response during Chlamydial Respiratory Infection

IL-10 to TNF alpha ratios throughout early first trimester can discriminate healthy pregnancies from pregnancy losses

Il Kalevala e la mitologia finnica in Italia : traduzioni, ricerche e letteratura

Vitamin D3 administration to MS patients leads to increased serum levels of latency activated peptide (LAP) of TGF-beta.

Differentiation of Tumorigenic C6 Glioma Cells Induced by Enhanced IL-6 Signaling.

Interleukin-6 promoter polymorphism and cardiovascular risk factors: The Health 2000 Survey.

Interleukin-6 promoter polymorphism and cardiovascular risk factors: The Health 2000 Survey.

Interleukin-6 promoter polymorphism and cardiovascular risk factors: The Health 2000 Survey.

Interleukin-6 promoter polymorphism and cardiovascular risk factors: The Health 2000 Survey.

Interleukin-6 promoter polymorphism and cardiovascular risk factors: the Health 2000 Survey.

Interleukin-8 secretion of human epithelial and monocytic cell lines induced by middle ear pathogens.

IL6 Gene Promoter Polymorphisms and Type 2 Diabetes: Joint Analysis of Individual Participants' Data From 21 Studies.

IL-23/IL-17 immunity as a hallmark of Crohn's disease.